Explore
Intelligence
Safety Audit ยท 20,118 ft
Personalized altitude sickness risk assessment for Shilla Peak Expedition. 60 seconds. No health data stored.
Shilla Peak Expedition at a Glance
At 20,118ft, altitude sickness is a genuine high-altitude hazard on Shilla Peak Expedition. The calculator above personalises your risk based on your medical history, prior altitude experience, and this route's specific ascent profile.
Frequently Asked Questions
High risk of AMS, HAPE, and HACE at 6,111m. Gradual ascent and strict acclimatization in Tabo/Kaza are critical.
The primary risks on Shilla Peak Expedition are: Severe Acute Mountain Sickness (AMS), Hidden crevasses on technical glaciers, Unpredictable extreme high-altitude weather and sub-zero temperatures. Your operator should brief you on each of these before departure.
Diamox (Acetazolamide) is worth discussing with your doctor if you plan to attempt Shilla Peak Expedition (20,118ft). It is not routinely required for healthy trekkers but is recommended if you have had AMS symptoms on a previous high-altitude trip. Never start Diamox without medical advice โ it has side effects including tingling fingers and increased urination.
At 6,132m, a resting SpO2 below 80% is a medical emergency and requires immediate descent. Between 80โ85% โ monitor closely and do not ascend further. Most acclimatized trekkers maintain 85โ92% at this altitude. Carry a pulse oximeter and check readings morning and night.
Solo climbing is strongly discouraged. The region is remote and technical; relying on self-rescue is extremely dangerous.
Compare verified operators who carry full oxygen support and pulse-oximetry checks.
Compare operators